Supplements|By The Weight Weight Team|August 8, 2026

Kratom Country Review – The Extracts Disclose No Alkaloid Content

Affiliate disclosure and scope

We earn a commission if you buy through the links on this page. All details were checked on 8 August 2026. We have written this one against our own commercial interest, because the alternative was to sell you something without telling you what it is.

This article is informational only and is not medical advice. Nothing here is FDA-approved to diagnose, treat, cure or prevent any disease.

Read This Before Anything Else

Kratom’s principal alkaloids — mitragynine, and 7-hydroxymitragynine, which is far more potent — act as partial agonists at mu-opioid receptors, the same receptor family targeted by morphine and oxycodone.

It produces tolerance, physical dependence and a withdrawal syndrome. That is pharmacology, not rhetoric, and it is the first fact about this product rather than a footnote to it.

We say this at the top of every kratom page we publish, because the category’s marketing is built around strain names and colours — red, green, white, Maeng Da, Bali — which invites you to shop as though you were choosing tea. You are choosing an opioid-receptor agonist.

If you are using kratom to manage opioid withdrawal or chronic pain, that is a real reason people reach for it and we are not going to pretend otherwise. But it is a reason to talk to a clinician about evidence-based options, not to order from a website. In the US, SAMHSA’s National Helpline is 1-800-662-4357 — free, confidential, 24/7.

The Extract Line Discloses Nothing

This is the finding that determines our rating, and it is specific.

Kratom Country sells a full concentrated-extract range:

Extract productReported priceAlkaloid content stated
Kratom gummies, 4-count$9.99None found
Kava and kratom shot$9.99None found
Liquid kratom shot$13.99None found
Extract soft gels, 10-countfrom $15.99None found
Enhanced extract powder, 20g$18.99None found
Extra strength tincture$33.99None found
Enhanced extract capsules, 10-count$34.99None found

No mitragynine percentage. No 7-hydroxymitragynine figure. No concentration ratio — not 10x, not 50x, nothing. No milligram-per-serving quantity. No dosing guidance. Products are described as “pre-measured” without stating what the measure is.

What the marketing does say is that the extracts are “concentrated” and “stronger than standard kratom powder or capsules.” That is a potency claim with no potency figure attached — it tells you the product is more powerful without telling you how much more.

For a leaf powder this would be poor practice. For a concentrated extract it is a different order of problem — and the reason is regulatory as much as pharmacological.

On 1 July 2026 the DEA announced the start of temporary scheduling to place concentrated 7-hydroxymitragynine above a specified threshold into Schedule I, following an FDA recommendation in July 2025. So the single number that determines whether an extract is a legal botanical product or a Schedule I controlled substance is the number this seller does not print.

You cannot establish the legality of what you are buying. You cannot establish its strength. And because 7-OH occurs in dried leaf at only about 0.011 to 0.039% by weight, while the American Kratom Association’s position is that genuine kratom should hold 7-OH at under 2% of total alkaloids, “it came from a leaf” does not bound the answer. Enriched and semi-synthetic 7-OH products sold as kratom are chemically distinct from botanical preparations.

What One Enforcement Case Shows the Range Really Is

It would be easy to treat the missing number as a paperwork failing. One enforcement action shows why it is not.

The Texas Attorney General sued kratom retailers over products found to contain up to 96% 7-hydroxymitragynine — nearly fifty times that state’s legal limit — alleging deceptive marketing.

Set 96% against leaf at 0.039%. That is not a variation in strength; it is a different substance wearing the same word. A buyer holding an unlabelled extract has no way to know which end of that range they are near.

We are not alleging Kratom Country sells anything like 96% 7-OH, and we have no evidence that it does. That is exactly the point: nobody can tell, including the buyer, because the figure is not published. The case establishes that the range is real and that unlabelled means unbounded.

The Kava Shot Is a Separate Problem

One product in the range deserves singling out: the combined kava and kratom shot at $9.99.

Kava carries its own hepatotoxicity signal. It has been associated with liver injury and has faced regulatory restriction in several countries on that basis. Kratom also carries a liver-injury signal, with cholestatic hepatitis reported in the literature.

Combining two substances that each carry an independent hepatotoxicity concern, in one ready-to-drink shot, sold for under ten dollars, with no stated quantity of either — we would want a great deal more information before recommending anyone go near it, and none of that information is available.

We could find no interaction study of the combination. Absence of study is not evidence of safety, and for a liver risk the sensible default is not to stack two signals and see.

Not AKA Qualified, and No Published COAs

The kratom market has one meaningful voluntary standard: the American Kratom Association’s GMP Standards Program, which audits participating vendors against good manufacturing practice.

As far as we could establish, Kratom Country is not a qualified vendor under it, and we found no reference to the programme — or to GMP in any form — on the pages we read. A different kratom seller we reviewed is qualified, and was among the first to be, which is the clearest single credential difference between them.

On testing, the pattern is one we have now seen repeatedly across this series: a described process with no published output.

The lab-testing page sets out a five-step protocol, and asks customers to contact the team for certificates of analysis.

It names no laboratory, links no results, and shows no sample certificate.

“Email us and we will send it” is not the same as publishing. It moves the burden onto the customer, it cannot be checked before you buy, and it cannot be checked by anyone comparing sellers. The brand we rated highest in the adjacent CBD category publishes batched certificates in a searchable database; that is what a testing claim looks like when it is backed.

What They Do Get Right

Two things, and we should say them plainly rather than write a review that is only prosecution.

The stated test list is a sensible one, and more specific than the vague “lab tested” badge most of this category uses. It covers:

  • Identity — species and origin verification
  • Alkaloids — identifying them and checking they have not been altered
  • Adulterants — foreign substances
  • Heavy metals — lead, arsenic, cadmium, mercury
  • Biological — salmonella, aerobic plate count, yeast, mould, coliforms, E. coli

Salmonella testing is not a box-tick in this category. The FDA issued a mandatory recall — an unusual step — over salmonella in powdered kratom from another manufacturer, so screening for it addresses a demonstrated failure mode rather than a hypothetical one. The stated alkaloid check for alteration is, on its face, aimed at exactly the enrichment problem described above; it is the publication of that result that is missing, not the intent.

Batch identification is real traceability. Products reportedly carry a sticker recording batch series, strain and date, which means a specific unit can be tied to a specific production run. That is more than several sellers manage, and it is the mechanism that would make a recall possible. It also means the COA you have to email for should, at least, be findable.

We also found no FDA warning letter, recall or import action naming this seller, which we looked for and did not find — though absence of a search finding is not proof of absence.

Where It Is Illegal, and the One Reversal

Leaf kratom is not federally scheduled in the US. State law is another matter.

As of July 2026, nine states ban kratom outright: Alabama, Arkansas, Connecticut, Indiana, Louisiana, Tennessee, Vermont and Wisconsin.

Individual counties and municipalities also ban it independently of state law, so a state-level green light is not the end of the question.

One genuinely interesting development: Rhode Island reversed its 2017 ban on 1 April 2026 — reportedly the first state ever to do so. The law here moves in both directions, which is a reason to check your own jurisdiction at the point of ordering rather than relying on any list, including this one.

And it bears repeating that the federal position on concentrated 7-OH is separate from the state position on leaf. A product can be sold in a state with no kratom ban and still sit inside a federal scheduling action, if its 7-OH content is high enough — which, on this seller’s extracts, you cannot determine.

The Litigation Picture

A structural point about the category rather than this seller specifically, and relevant to anyone weighing a purchase.

Wrongful death and product liability litigation against kratom manufacturers, distributors and retailers is expanding across US jurisdictions, with claims spanning strict liability, negligence, failure to warn, breach of warranty, fraud and wrongful death. Municipal action exists too — Baltimore has sued kratom makers under a local ordinance.

Failure to warn is the claim to notice here, because it is about labelling and disclosure rather than the product itself — the same territory as an extract sold with no potency figure. We make no claim about this seller’s exposure. But a category facing an expanding failure-to-warn docket is one where a seller choosing not to print numbers is making a choice, not following a norm.

Kilogram Pricing on a Dependence-Forming Substance

Powder is reported at roughly $95 to $130 per kilogram depending on strain, with a rewards programme giving a point per dollar spent.

In most categories we treat volume pricing as a straightforward positive. Here we do not. A kilogram is an enormous quantity of a substance that produces tolerance — meaning the amount required rises with continued use — and the cheapest unit price is available precisely at the quantity most likely to sustain escalating consumption.

A loyalty scheme that rewards cumulative spending on an opioid-receptor agonist raises the same issue in a milder form. Neither is unique to this seller — kilo pricing is the category norm — but the category norm is worth naming rather than reporting as value.

Side Effects, Interactions and Who Must Not Use It

Do not use kratom at all if you are:

  • Pregnant. Neonatal withdrawal following maternal kratom use is documented.
  • Breastfeeding.
  • Taking any opioid, benzodiazepine, sedative or alcohol. Combined respiratory depression is the mechanism behind a substantial share of serious kratom-associated cases.
  • Taking an SSRI, SNRI, MAOI, tramadol or another serotonergic drug.
  • Living with liver disease, or taking anything else with a hepatotoxicity signal.
  • Under 21, which the seller’s own footer states.

Reported effects include nausea, vomiting, constipation, itching, dizziness, sedation, tachycardia, seizure, liver injury, dependence and withdrawal. The constipation point matters on this site specifically: opioid-receptor activity slows gut transit, and GLP-1 medications already commonly cause constipation. Stacking them is a predictable problem, and there is no interaction safety data for kratom alongside GLP-1 drugs.

Kratom is not a weight-loss product, has not been studied as one, and appears on this site only because it was in our review queue.

How It Compares to Other Kratom Sellers

Kratom CountrySuper SpeciosaKingdom Kratom
AKA GMP qualifiedNot establishedYes, among the firstNot established
COAs publishedNo — request by emailTesting programme documentedNone found
Concentrated extracts soldYes, full range, unlabelledLeaf-focusedLeaf-focused
Batch traceabilityYes — series, strain, dateYesNot established
Our rating1.6 / 52.0 / 51.8 / 5

No kratom seller scores well here, because the ceiling is set by what the substance is rather than by how well anyone sells it. Within that ceiling, the AKA GMP qualification is what separates the top of this table from the rest, and the unlabelled extract range is what puts Kratom Country below a seller with comparable opacity but a leaf-focused catalogue.

Pros and Cons

Pros

  • Specific five-step test list, more concrete than a “lab tested” badge
  • Salmonella screening addresses a demonstrated failure mode in this category
  • Batch ID stickers record series, strain and date — real traceability
  • Alkaloid check is stated to cover alteration, not just presence
  • Money-back guarantee reported
  • No FDA warning letter, recall or import action naming this seller found
  • Age-restriction and pregnancy warnings present in the footer

Cons

  • Kratom acts on mu-opioid receptors; dependence and withdrawal are expected
  • Full extract range with no mitragynine or 7-OH figure anywhere
  • No concentration ratio, no mg per serving, no dosing guidance
  • DEA temporary Schedule I action on concentrated 7-OH began 1 July 2026
  • Not an AKA GMP qualified vendor as far as we could establish
  • No published COAs — customers must email to request them
  • No testing laboratory named
  • Kava and kratom shot stacks two hepatotoxicity signals, both unquantified
  • Banned outright in nine states, plus local ordinances
  • Kilogram pricing and a spend-based loyalty scheme on a tolerance-forming substance

If You Are Going to Buy Anyway

Our recommendation is not to, and we would say that about the category rather than this seller. But people will, and a page that only says no is not useful to them. So:

  • Avoid the extracts specifically. Leaf powder is the more predictable product, and the extracts here carry the entire unlabelled-potency problem. This is the single most consequential choice on the site.
  • Avoid the kava combination for the liver reason above.
  • Email for the certificate of analysis before you order, not after. The batch ID system means it should exist. If it does not arrive, that answer is itself informative.
  • Check your state and your city. Nine states ban it, local ordinances exist, and the law moved in both directions this year.
  • Never combine it with opioids, benzodiazepines, sedatives or alcohol. This is the combination behind the serious cases.
  • Keep any dose low and stable, and do not use it daily. Tolerance is what turns occasional use into dependence, and escalation is the mechanism.
  • Tell your doctor you are taking it, particularly before surgery or if you are prescribed anything serotonergic.

And if you are using it for opioid withdrawal or unmanaged pain, the better route is a clinician. SAMHSA National Helpline: 1-800-662-4357.

Limitations of This Review

We have not bought, used or independently tested any Kratom Country product, and we have not requested a certificate of analysis from them — it is possible that emailing produces a complete and reassuring document. Our criticism is that it is not published where a buyer or a comparison can see it, not that it does not exist.

The absence of alkaloid figures is an absence we searched for and did not find on the pages we read; it is possible a figure appears on individual product pages, packaging or a document we did not reach. Pricing is as displayed and changes. AKA GMP status is our reading of available material rather than a confirmation from the association, and a vendor could have qualified since. We found no FDA action naming this seller, but absence of a search finding is not proof of absence. We did not read a Trustpilot or BBB record and publish no customer satisfaction score.

The regulatory position is moving. The temporary scheduling process for concentrated 7-OH began on 1 July 2026 and may have progressed since; state law changed in both directions this year. Verify current law yourself. Adverse-event and case data are reported from surveillance systems, which capture association rather than proven causation. None of this is medical or legal advice.

Frequently Asked Questions

What is kratom, in plain terms?

A tree leaf whose main alkaloids, mitragynine and the far more potent 7-hydroxymitragynine, act as partial agonists at mu-opioid receptors — the same receptor family as morphine and oxycodone. That is not a scare comparison, it is the pharmacology. It produces tolerance, dependence and a withdrawal syndrome. Any decision about buying it should start there rather than with strain names.

Does Kratom Country say how strong its extracts are?

No. Across the extract range — gummies, liquid shots, tinctures, soft gels, enhanced extract powder and capsules — we found no mitragynine percentage, no 7-hydroxymitragynine figure, no concentration ratio such as 10x or 50x, and no milligram-per-serving number. The marketing says the extracts are concentrated and stronger than powder, which quantifies nothing.

Why does the missing 7-OH figure matter so much right now?

Because concentrated 7-hydroxymitragynine is the subject of an active federal scheduling action. The DEA announced the start of temporary scheduling to place 7-OH above a specified threshold into Schedule I on 1 July 2026, following an FDA recommendation in July 2025. If a product does not state its 7-OH content, you cannot tell whether it falls above that threshold — meaning you cannot establish what you are buying is legal.

How much 7-OH is in ordinary kratom leaf?

Very little. Reported ranges for dried leaf and powder are roughly 0.011 to 0.039% by weight, and the American Kratom Association position is that genuine kratom should contain 7-OH at less than 2% of total alkaloids. Chemically enriched and semi-synthetic 7-OH products sold as kratom are chemically distinct from botanical preparations, which is precisely why an unlabelled extract is a different proposition from an unlabelled leaf powder.

Is Kratom Country AKA GMP qualified?

Not as far as we could establish, and we found no reference to the American Kratom Association GMP Standards Program or to GMP of any kind on the pages we read. Another kratom seller we reviewed is a qualified vendor under that programme and was among the first, which is the single clearest credential difference between them.

Are certificates of analysis published?

Not that we could find. The lab-testing page describes a five-step process and asks customers to contact the team for certificates of analysis, but names no laboratory and links no results or sample documents. A described process with no published output is a claim rather than evidence.

Where is kratom banned?

As of August 2026, eight states ban it outright: Alabama, Arkansas, Connecticut, Indiana, Louisiana, Tennessee, Vermont and Wisconsin. Various counties and municipalities ban it independently of state law. Rhode Island reversed its 2017 ban on 1 April 2026, the first state to have done so. Check current local law yourself, because this is moving.

Can it help with weight loss?

No, and nothing on this site should be read as suggesting so. Kratom is not a weight-loss product, has not been studied for that purpose, and its opioid-receptor activity causes constipation — which compounds a side effect people on GLP-1 medications already commonly experience. There is no interaction safety data for kratom alongside GLP-1 drugs.

Verdict

1.6 / 5

A concentrated extract range sold without a single potency figure, while the DEA schedules the exact compound those extracts concentrate. Better traceability than the worst of this category, and a worse catalogue.

Every kratom review we publish starts from the same fact: the active alkaloids are partial agonists at mu-opioid receptors, and dependence is an expected outcome rather than a rare complication. That caps what any seller in this category can score.

Within that cap, this one lands low for a specific and checkable reason. Kratom Country sells gummies, shots, tinctures, soft gels and enhanced extract powder and capsules, and states no mitragynine percentage, no 7-hydroxymitragynine figure, no concentration ratio and no milligram-per-serving quantity for any of them — while telling you they are stronger than powder. That is a potency claim without a potency number.

The timing is what makes it serious. In July 2026 the DEA gave notice of intent to place concentrated 7-OH temporarily in Schedule I — an order that had not issued as of August 2026, so 7-OH is not currently a controlled substance. The figure that determines whether an extract is a legal botanical or a controlled substance is the figure not printed. And one state attorney general has sued over products found at 96% 7-OH against leaf at 0.039%, which establishes that unlabelled means unbounded. We are not suggesting this seller is anywhere near that — we are saying nobody can tell, and that is the problem.

The kava and kratom shot compounds it, stacking two hepatotoxicity signals in one under-ten-dollar drink with neither quantity stated and no interaction study we could find.

They are not the worst operator in this category, and we should be fair about it. The five-step test list is more specific than most, salmonella screening addresses a real documented failure, and batch stickers recording series, strain and date are genuine traceability that several rivals lack. The testing intent looks real; the publication is missing. “Email us for the COA” shifts the burden onto the buyer and makes comparison impossible.

If you are going to buy kratom, buy leaf powder from an AKA GMP qualified vendor and skip extracts entirely. That advice costs us money on this page and it is still the advice.

Before You Consider This At All

Kratom acts on the same receptor family as opioids and causes dependence. It is banned outright in nine states, concentrated 7-OH entered a federal temporary scheduling process on 1 July 2026, and this seller publishes no alkaloid content for its extracts, so you cannot establish their strength or legality. If you use it anyway: avoid the extracts and the kava combination, request the batch certificate before ordering, never combine it with opioids, benzodiazepines, sedatives or alcohol, and tell your doctor. If you are managing withdrawal or pain, call SAMHSA on 1-800-662-4357. This page is informational only and is not medical or legal advice.